1Crager M, Wijayawardana SR, Gruver AM, et al. Correlation of the oncotype DX breast recurrence score and the Ki-67 IHC MIB-1 pharmDx score in HR+, HER2-, node-positive early breast cancer. Abstract presented at: 58th Annual Meeting of the American Society of Clinical Oncology (ASCO); June 3-7, 2022; Chicago, IL. Accessed May 26, 2022. https://meetings.asco.org/abstracts-presentations/211887/video
2Crager M, Wijayawardana SR, Gruver AM, et al. Correlation of the oncotype DX breast recurrence score and the Ki-67 IHC MIB-1 pharmDx score in HR+, HER2-, node-positive early breast cancer. Abstract presented at: 58th Annual Meeting of the American Society of Clinical Oncology (ASCO); June 3-7, 2022; Chicago, IL. Accessed April 24, 2023. https://meetings.asco.org/abstracts-presentations/211887/video